Mass Spectrometry for Drug Target Discovery
Mass Spectrometry is key technology for studying critical molecules and pathways. Defining molecular targets is crucial for the process of drug development.
Main Heading
Mass spectrometry-based platforms in the CMD cover a wide range of applications and are overseen by specialist teams and groups:
- Mass Spectrometry in the Ubiquitin/UBL System
- Discovery Proteomics
- Protein Mass Spectrometry
- Single Cell & Spatial Proteomics
- Structural and Mechanistic Proteomics
- Drug & substrate assay MS screening
- Metabolomics & Lipidomics